| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |